NewsRoom Articles - Page 88 of 238

WednesdayAug 30, 2023 1:47 pm

UC San Diego Researchers Suggest Stem Cell Transplantation Could Treat Alzheimer’s

Ongoing research into a potential cure for Alzheimer’s disease has revealed that stem cell transplantation may be the key to treating the debilitating mental disease. Ongoing research at the University of California San Diego has pointed to stem cell transplants as a promising alternative treatment for the mental condition. Alzheimer’s disease affects parts of the brain that are involved in language, thought and memory, causing a steady decline in memory and cognitive abilities that eventually robs patients of their ability to take part in their day-to-day lives or even hold meaningful conversations. There are no existing cures for the neurodegenerative…

WednesdayAug 30, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Celebrates Receipt of Orphan Drug Designation, Third Fast Track Designation Amid Preparations for Planned Acclaim-3 Clinical Trial

Genprex recently received orphan drug designation for its lead drug candidate REQORSA(R) Immunogene Therapy (quratusugene ozeplasmid) for the treatment of small cell lung cancer (“SCLC”) The company also celebrated receipt of its third Fast Track Designation (“FTD”), granted by the FDA, this time for REQORSA Immunogene Therapy, in combination with Tecentriq in patients with extensive stage small cell lung cancer (“ES-SCLC”) The orphan drug designation (“ODD”) in combination with the FTD is an indication of the great need for better treatment options for patients with ES-SCLC, and non-small cell lung cancer (“NSCLC”), according to Genprex President, Chairman, and CEO Rodney…

TuesdayAug 29, 2023 1:01 pm

AI Helps Forecast Brain Tumor Outcomes

A team of researchers, including scientists from Stanford Medicine, has created an artificial intelligence (AI) model capable of forecasting brain tumor outcomes by examining stained images of a type of brain cancer called glioblastoma. The researchers published a paper describing how the AI model could help physicians identify cellular markers for more aggressive tumors in patients before marking them for expedited follow-ups. Brain cancers tend to have poor outcomes because their proximity to important brain tissue makes them incredibly hard to treat via conventional methods such as surgery and radiation without harming healthy tissue. The blood-brain barrier, which is a…

MondayAug 28, 2023 12:27 pm

England Sees Soaring Numbers of Hospitalizations for Severe Allergies

A leading national patient United Kingdom charity is concerned with the “hugely worrying” rise of allergy-related hospitalizations in England. Dangerous allergic reactions in the UK have risen in recent years and now average around 25,000 NHS hospital stays every year. According to health officials, the rate of allergy reactions in the country has grown by more than two times over the past two decades. Allergy UK posits that the increase in allergy admission rates is due to the influx of a wide variety of foods from around the globe coupled with a surge in birch tree numbers. Data from the…

FridayAug 25, 2023 10:32 am

Blockchain Could Help Improve Security, Transparency in Healthcare eCommerce

The past couple of years has seen major e-commerce companies such as Amazon, Walgreens and Walmart make inroads into the healthcare sector. Healthcare adopted e-commerce features in the wake of the coronavirus pandemic to limit contact with the public and reduce the rate of infection. Features such as virtual doctor appointments, examinations, medication purchases and home deliveries have become more commonplace over the past few years due to the convenience and expanded access they offer to customers. Retail giant Amazon cemented its entry into the healthcare industry with its $3.9 billion acquisition of One Medical, a primary care provider with…

FridayAug 25, 2023 9:45 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to Unlock Potential Treatments and Cures for Serious Infectious Diseases and Cancer

Renovaro’s current product development pipeline includes a variety of treatment candidates spanning cancer, HIV, and HBV Renovaro’s Pre-Investigational New Drug (pre-IND) submission included a human study plan covering pancreatic cancer, as well as other cancers that are difficult to treat The company recently entered into an LOI with GEDi Cube that could enhance the efficacy of upcoming trials and speed up delivery results As an advanced, pre-clinical biotechnology company specializing in cell, gene, and immunotherapy, Renovaro BioSciences (NASDAQ: RENB), formerly Enochian BioSciences Inc., aims to unlock potentially long-term or life-long cancer remission in some of the deadliest cancers and to…

ThursdayAug 24, 2023 2:05 pm

Australia Brings New HIV Infections to Near Zero

Central districts in the Australian city of Sydney may soon break HIV infection records by becoming the first places in the world to achieve the United Nation’s target for eliminating HIV transmission. Researchers note that several Sydney districts are close to hitting UN targets for HIV infection, putting the country on track to achieving a 90% drop in new HIV cases by 2030. Several decades ago Sydney was in the grip of an HIV pandemic that took thousands of gay men's lives between the 1980s and 1990s. Between 2010–2022, however, new cases among gay men in the city went down…

WednesdayAug 23, 2023 2:04 pm

Canadian Researchers Design Powerful Imaging Tech to Boost Cancer Fight

Canadian researchers have developed a powerful imaging technique that would aid physicians in their fight against cancer. The team from the School of Biomedical Engineering at Dalhousie University in Canada has designed a high-resolution endoscopic surgical and imaging probe, the very first in the world capable of allowing surgeons to see brain tumors in 10 times more resolution than traditional imaging technologies such as CT and MRI scans. Brain cancers are among the most debilitating types of cancer, affecting tens of thousands of Americans each year, and are forecast to take close to 20,000 lives in 2023. Tumors of the…

WednesdayAug 23, 2023 9:45 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

For the quarter ended June 30, 2023, RVLP reported net sales of $8.3 million and operating expenses of $14.4 million, down 2% and 32%, respectively, compared to the prior year period; this strategy is designed to extend cash runway for future business development and changes in the company’s marketing mix The company’s marketing partner, Santen, has commenced the required registrational trial for UPNEEQ(R) in Japan and plans to begin the same in China in 2023 UPNEEQ(R) has strong U.S. intellectual property protection, with patents extending to 2039 RVL Pharmaceuticals launched its prescription ecommerce platform, Elevate, in July 2023, allowing providers…

WednesdayAug 23, 2023 9:00 am

Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer

Combination of advanced AI machine learning technology and proven immunotherapy technology seen as “future of medicine” Demonstrated success that both companies have shown with their innovative developments is expected to expand synergistically Potential applications against variety of cancers The announcement of a binding and exclusive letter of intent to merge, between two of the most innovative companies in their respective fields, is seen as representing a potentially transformative step in the fight against cancer. Considering Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy, that has already demonstrated significant results with its technology against pancreatic…